Company profile CARM
After 39 days of this quarter the interest is at 164.0. Based on that we can calculate that during remaining 52 days it will total up to 383.0. Carisma Therapeutics expected interest is significantly higher compared to previous quarter (+47.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 41 | 115 180.5% QoQ | 115 0.0% QoQ | 147 27.8% QoQ |
| 2020 | 139 239.0% YoY -5.4% QoQ | 142 23.5% YoY 2.2% QoQ | 107 -7.0% YoY -24.6% QoQ | 92 -37.4% YoY -14.0% QoQ |
| 2021 | 158 13.7% YoY 71.7% QoQ | 161 13.4% YoY 1.9% QoQ | 56 -47.7% YoY -65.2% QoQ | 65 -29.3% YoY 16.1% QoQ |
| 2022 | 303 91.8% YoY 366.2% QoQ | 130 -19.3% YoY -57.1% QoQ | 384 585.7% YoY 195.4% QoQ | 203 212.3% YoY -47.1% QoQ |
| 2023 | 319 5.3% YoY 57.1% QoQ | 361 177.7% YoY 13.2% QoQ | 277 -27.9% YoY -23.3% QoQ | 260 28.1% YoY -6.1% QoQ |
| 2024 | 164 -48.6% YoY -36.9% QoQ | - | - | - |
The average 5 years interest of Carisma Therapeutics was 14.33 per week. The last year interest of Carisma Therapeutics compared to the last 5 years has changed by 75.79%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 192.23%.
There is not enough data for Carisma Therapeutics news to provide analysis
There is not enough data for Carisma Therapeutics news to provide correlation calculation
There is not enough data for Carisma Therapeutics news to provide analysis
After 34 days of this quarter the interest is at 27.0. Based on that we can calculate that during remaining 58 days it will total up to 73.0. CAR macrophages expected interest is significantly lower compared to same quarter last year (-49.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 182 |
| 2019 | 137 -24.7% QoQ | 21 -84.7% QoQ | 120 471.4% QoQ | 126 -30.8% YoY 5.0% QoQ |
| 2020 | 20 -85.4% YoY -84.1% QoQ | 30 42.9% YoY 50.0% QoQ | 93 -22.5% YoY 210.0% QoQ | 81 -35.7% YoY -12.9% QoQ |
| 2021 | 246 1130.0% YoY 203.7% QoQ | 22 -26.7% YoY -91.1% QoQ | 147 58.1% YoY 568.2% QoQ | 51 -37.0% YoY -65.3% QoQ |
| 2022 | 174 -29.3% YoY 241.2% QoQ | 101 359.1% YoY -42.0% QoQ | 91 -38.1% YoY -9.9% QoQ | 145 184.3% YoY 59.3% QoQ |
| 2023 | 91 -47.7% YoY -37.2% QoQ | 69 -31.7% YoY -24.2% QoQ | 112 23.1% YoY 62.3% QoQ | 27 -81.4% YoY -75.9% QoQ |
The average 5 years interest of CAR macrophages was 8.02 per week. The last year interest of CAR macrophages compared to the last 5 years has changed by -7.23%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -25.3%.
After 39 days of this quarter the interest is at 363.0. Based on that we can calculate that during remaining 52 days it will total up to 847.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 384 | 647 68.5% QoQ | 651 0.6% QoQ | 619 -4.9% QoQ |
| 2020 | 592 54.2% YoY -4.4% QoQ | 472 -27.0% YoY -20.3% QoQ | 537 -17.5% YoY 13.8% QoQ | 549 -11.3% YoY 2.2% QoQ |
| 2021 | 595 0.5% YoY 8.4% QoQ | 666 41.1% YoY 11.9% QoQ | 683 27.2% YoY 2.6% QoQ | 727 32.4% YoY 6.4% QoQ |
| 2022 | 895 50.4% YoY 23.1% QoQ | 886 33.0% YoY -1.0% QoQ | 864 26.5% YoY -2.5% QoQ | 833 14.6% YoY -3.6% QoQ |
| 2023 | 909 1.6% YoY 9.1% QoQ | 916 3.4% YoY 0.8% QoQ | 930 7.6% YoY 1.5% QoQ | 964 15.7% YoY 3.7% QoQ |
| 2024 | 363 -60.1% YoY -62.3% QoQ | - | - | - |
The average 5 years interest of CAR therapy was 56.25 per week. The last year interest of CAR therapy compared to the last 5 years has changed by 25.3%. The interest for CAR therapy is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 43.05%.
After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0. Carisma Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 138 |
| 2019 | 69 -50.0% QoQ | 0 -100.0% QoQ | 77 inf% QoQ | 48 -65.2% YoY -37.7% QoQ |
| 2020 | 0 -100.0% YoY -100.0% QoQ | 72 inf% YoY inf% QoQ | 35 -54.5% YoY -51.4% QoQ | 89 85.4% YoY 154.3% QoQ |
| 2021 | 37 inf% YoY -58.4% QoQ | 77 6.9% YoY 108.1% QoQ | 212 505.7% YoY 175.3% QoQ | 31 -65.2% YoY -85.4% QoQ |
| 2022 | 86 132.4% YoY 177.4% QoQ | 67 -13.0% YoY -22.1% QoQ | 36 -83.0% YoY -46.3% QoQ | 68 119.4% YoY 88.9% QoQ |
| 2023 | 86 0.0% YoY 26.5% QoQ | 147 119.4% YoY 70.9% QoQ | 148 311.1% YoY 0.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Carisma Therapeutics stock was 5.86 per week. The last year interest of Carisma Therapeutics stock compared to the last 5 years has changed by 47.27%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 58.06%.
There is not enough data for Carisma Therapeutics company profile to provide analysis
There is not enough data for Carisma Therapeutics company profile to provide correlation calculation
There is not enough data for Carisma Therapeutics company profile to provide analysis
There is not enough data for Carisma Therapeutics biopharmaceutical to provide analysis
There is not enough data for Carisma Therapeutics biopharmaceutical to provide correlation calculation
There is not enough data for Carisma Therapeutics biopharmaceutical to provide analysis
There is not enough data for Carisma Therapeutics Philadelphia to provide analysis
There is not enough data for Carisma Therapeutics Philadelphia to provide correlation calculation
There is not enough data for Carisma Therapeutics Philadelphia to provide analysis
There is not enough data for Carisma Therapeutics chimeric antigen receptors to provide analysis
There is not enough data for Carisma Therapeutics chimeric antigen receptors to provide correlation calculation
There is not enough data for Carisma Therapeutics chimeric antigen receptors to provide analysis
There is not enough data for Carisma Therapeutics Moderna collaboration to provide analysis
There is not enough data for Carisma Therapeutics Moderna collaboration to provide correlation calculation
There is not enough data for Carisma Therapeutics Moderna collaboration to provide analysis